Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571077 · ClinicalTrials.gov registry record
Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study
A clinical trial of Thyroid Neoplasms and Thyroid Nodules, sponsored by Hadassah Medical Organization.
- Completed
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT00571077: Completed study of Thyroid Neoplasms and Thyroid Nodules, sponsored by Hadassah Medical Organization.
NCT00571077 is a study of Thyroid Neoplasms and Thyroid Nodules that has completed, run by Hadassah Medical Organization. The registered enrollment target is 200 participants, below the 811-participant average among 7 other Thyroid Neoplasms trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571077, a study of Thyroid Neoplasms and Thyroid Nodules, has completed, sponsored by Hadassah Medical Organization.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients over the age of 18 with thyroid nodules scheduled for surgery will undergo EIS scan. Each node will be scanned and graded form 1-5 (1=benign, 5=malignant). Results will be compared with final histopathology.
Conditions Studied
Interventions
- DEVICE Electrical Impedance Scanning (EIS) of the Thyroid gland
Study Locations (2)
District of Columbia
- Walter Reed Army MEdicla Center - Washington D.C.
Other
- Hadassah-Hebrew University Medical Center - Jersualem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-01 |
| Est. Completion | 2007-12 |
What the finished NCT00571077 record still lists
NCT00571077 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 811-participant average among 7 other Thyroid Neoplasms trials with a reported enrollment target (75% lower).
The record links to 2 conditions, with Thyroid Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Electrical Impedance Scanning (EIS) of the Thyroid gland is the first listed.
NCT00571077 reports a single indexed study location in District of Columbia, Other.
Frequently Asked Questions
What is clinical trial NCT00571077 about?
NCT00571077 is a clinical study titled "Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study". Patients over the age of 18 with thyroid nodules scheduled for surgery will undergo EIS scan. Each node will be scanned and graded form 1-5 (1=benign, 5=malignant). Results will be compared with final histopathology.
What is the current status of trial NCT00571077?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2002-01. Estimated completion is 2007-12.
What conditions does trial NCT00571077 study?
This clinical trial studies the following conditions: Thyroid Neoplasms, Thyroid Nodules.
What interventions are being tested in trial NCT00571077?
The interventions under investigation include: Electrical Impedance Scanning (EIS) of the Thyroid gland (DEVICE).
Who is sponsoring clinical trial NCT00571077?
This trial is sponsored by Hadassah Medical Organization, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00571077 being conducted?
This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
RECRUITING · NA
-
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
RECRUITING
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RECRUITING
-
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
ACTIVE NOT RECRUITING · Phase 1
-
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia